Home > Specialties > IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, PTEN

IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, PTEN

Definition : Molecular assay reagents intended to identify mutations in the phosphatase and tensin homologue (PTEN) gene, located at chromosome 10q23.3, which encodes for a protein that acts as a tumor suppressor. This genetic mutation has been identified in patients with PTEN hamartoma tumor syndrome (PHTS), a family of diseases that includes Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), Proteus syndrome (PS), and Proteus-like syndrome, which is characterized by similar but not all Proteus syndrome features.

Entry Terms : "Cancer Gene Mutation Reagents" , "Bannayan-Riley-Revalcaba Syndrome Gene Mutation Reagents" , "Proteus-Like Syndrome (CS) Gene Mutation Reagents" , "Proteus Syndrome (PS) Gene Mutation Reagents" , "Cowden Syndrome (CS) Gene Mutation Reagents" , "Hamartoma Tumor Syndrome Gene Mutation Reagents" , "PTEN Hamartoma Tumor Syndrome (PHTS) Gene Mutation Reagents" , "PTEN Gene Mutation Detection Reagents" , "Reagents, Molecular Assay, Gene Anomaly, Mutation, PTEN"

UMDC code : 24929

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-6 of 6 Match(es).

BioLegend Inc

Company Type: Parent

Echelon Biosciences Inc (EBI)

Company Type: Parent

Illumina Inc

Company Type: Parent

Illumina has developed a comprehensive line of products that address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine. Our products and services are used by a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.

Myriad Genetics Inc

Company Type: Parent

United Bio Research Inc

Company Type: Parent

United Biotech, Inc was founded in 1984. UBI develops and manufactures products tailored to the need of medical professionals in engineering healthcare economies. From conception, products are designed for reliability, ease of use and cost effectiveness. Our products are unique for clinical assays in that all assays can be used with any open-ended 96-well platform (eg. universal microtiter plate reader).

ZeptoMetrix Corp

Company Type: Parent

ZeptoMetrix is a privately held company formed in 1999 to serve the diagnostic and pharmaceutical research products industries. In 2003, the company acquired the BioClinical Partners division of Impath Corporation and a highly complementary and successful partnership was formed.

1-6 of 6 Match(es).

 

Medical Product Guide Optometric Management Product Guide